摘要
骨质疏松是一种以骨密度降低、骨量减少和骨组织显微结构退化为特征的代谢紊乱性疾病,能导致骨脆性增加,增高骨折的风险性。骨密度(BMD)是描述骨特征和诊断骨质疏松的数量性状,认为是最重要的预测骨质疏松性骨折的因子。
出处
《实用临床医学(江西)》
CAS
2011年第1期133-136,138,共5页
Practical Clinical Medicine
参考文献40
-
1Uitterlinden A G, Weel A E,Burger H,et al. Interaction be- tween the vitamin D receptor gene and collagen type Ialphal gene in susceptibility for Iracture[J]. J Bone Miner Res,2001, 16(2) :379-385.
-
2Krall E A,Dawson Hughes B. Heritable and life-style determi- nants of bone mineral density[J]. J Bone Miner Res, 1993,8 (1) : 1-9.
-
3Stewart T L,Ralston S H. Role of genetic factors in the patho- genesis of osteoporosis[J]. J Endocrinol, 2000, 166 (2) :235- 245.
-
4Recker R R, Deng H W. Role of genetics in osteoporosis[J]. Endocrine, 2002,17 ( 1 ) : 55-66.
-
5Deroo B J,Korach K S. Estrogen receptors and human disease [J] Clin Invest,2006,116(3) :561-570.
-
6Koehler K F, Helguero L A, Haldosen L A, et al. Reflections on the discovery and significance of estrogen receptor beta[J]. Endocr Rev,2005,26(3) :465-478.
-
7Chagin A S, Lindberg M K, Andersson N, et al. Estrogen re- ceptor-beta inhibits skeletal growth and has the capacity to mediate growth plate fusion in female mice[J]. J Bone Miner Res,2004,19(1) :72-77.
-
8Couse J F, Lindzey J,Grandien K, et al. Tissue distribution andquantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse[J]. Endocrinolo- gy, 1997,138(11) :4613-4621.
-
9Schuit S C, De Jong F H,Stolk L, et al. Estrogen receptor al- pha gene polymorphisms are associated with estradiol levels in postnaenopausal women[J]. Eur J Endoerinol, 2005,153 (2) : 327-334.
-
10Gennari L, Merlotti D, de Paola V, et al. Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review[J]. Am J Epidemiol, 2005,161 (4) : 307-320.
二级参考文献19
-
1Schuit SC,Van Meurs JB,Bergink AP,et al.Height in pre-and postmenopausal women is influenced by estrogen receptor alpha gene polymorphisms.J Clin Endocrinol Metab,2004,89(1):303-309
-
2Van Meurs JB,Schuit SC,Weel AE,et al.Association of 5' estrogen receptor alpha gene polymorphisms with bone mineral density,vertebral bone area and fracture risk.Hum Mol Genet,2003,12(14):1745-1754
-
3Salmen T,Heikkinen AM,Mahonen A,et al.Relation of estrogen receptor-alpha gene polymorphism and hormone replacement therapy to fall risk and muscle strength in early postmenopausal women.Ann Med,2002,34(1):64-72
-
4Garnero P,Munoz F,Borel O,et al.Vitamin D Receptor gene polymorphisms are associated with the risk of fractures in postmenopausal women,independently of bone mineral density.The OFELY study.J Clin Endocrinol Metab,2005,90 (8):4829-4835
-
5Yaozhong L,Yongjun L,Robert RR,et al.Molecular studies of identification of genes for osteoporosis:the 2002 update.J Endocrinol,2003,177:147-196
-
6Gennari L,Becherini L,Falchetti A,et al.Genetics of osteoporosis:role of steroid hormone receptor gene polymorphisms.J Steroid Biochem Mol Biol,2002,81(1):1-24
-
7Jianmin L,Hanmin ZH,Xiaoying ZH,et al.Estrogen receptor gene polymorphisms and bone mineral density in Chinese postmenopausal women.Chin Med J,2003,116(3):364-367
-
8Sapir-Koren R,Livshits G,Kobyliansky E.Association and linkage disequilibrium analyses suggest genetic effects of estrogen receptor alpha and collagen IA1 genes on bone mineral density in Caucasian women.Calcif Tissue Int,2003,72(6):643-650
-
9Albagha OM,McGuigan FE,Reid DM,et al.Estrogen receptor alpha gene polymorphisms and bone mineral density:haplotype analysis in women from the United Kingdom.J Bone Miner Res,2001,16(1):128-134
-
10Han K,Choi J,Moon I,et al.Non-association of estrogen receptor genotypes with bone mineral density and bone turnover in Korean pre-,peri-,and postmenopausal women.Osteoporos Int,1999,9(4):290-295
共引文献44
-
1柳林,董砚虎,司元国,曲宁.雌激素受体基因多态性与2型糖尿病骨量的关系[J].中国骨质疏松杂志,2004,10(4):466-470. 被引量:2
-
2孙珉丹,林承赫,邹洪斌,杨立明,迟宝荣.中国长春地区绝经前汉族女性维生素D受体基因多态性与骨代谢指标的关系[J].吉林大学学报(医学版),2005,31(2):319-321. 被引量:1
-
3佘敦敏,章秋.雌激素受体基因与绝经后骨质疏松[J].安徽医药,2005,9(4):241-243. 被引量:10
-
4张秀珍,李颖,钱国锋,韩峻峰.绝经后妇女雌激素受体基因多态性与骨和脂代谢的相关性研究[J].中国骨肿瘤骨病,2005,4(4):229-233. 被引量:6
-
5郭三巧,李东,王芊,薛延.雌激素受体基因PvuⅡ和XbaI多态性与骨密度的关系研究[J].中国全科医学,2006,9(3):200-203. 被引量:8
-
6谢建萍,龚先琼,谭德明,刘菲,周建亮.雌激素受体基因多态性与乙型肝炎肝硬化的相关性研究[J].中南大学学报(医学版),2006,31(3):379-382. 被引量:15
-
7何进卫,章振林,秦跃娟,黄琪仁,胡云秋,李淼,张浩,胡伟伟,刘玉娟.白介素1受体拮抗剂基因多态性与上海市绝经后妇女骨密度无相关性[J].中国骨质疏松杂志,2006,12(3):229-231.
-
8陈富强,朱晓平,钱小虎,杨钰琴,范丽安.雌激素受体基因多态性与子宫肌瘤的相关研究[J].中国妇产科临床杂志,2006,7(4):290-291. 被引量:11
-
9王立平.原发性骨质疏松候选基因的研究进展[J].内蒙古医学院学报,2006,28(5):480-484. 被引量:1
-
10白雪,王毅,于顺禄.骨质疏松相关基因的研究进展[J].中国骨伤,2006,19(9):573-576. 被引量:7
同被引文献45
-
1镐英杰,陈凤苞,唐煜,裴福兴.雌激素替代疗法对去卵巢大鼠血清一氧化氮及骨显微结构的影响[J].中国临床康复,2005,9(7):102-103. 被引量:3
-
2林伟春,梁婉仪,郑黎勤,杨思为.艾灸与雌激素替代治疗绝经后骨质疏松症的疗效比较[J].中医药导报,2006,12(7):63-65. 被引量:15
-
3伍雪丽,张帆,黄萍.雌激素受体XbaⅠ和PvuⅡ基因多态性与慢性牙周炎的相关研究[J].实用口腔医学杂志,2007,23(5):716-720. 被引量:4
-
4Yoshiji Yamad. Association of a LeulO—?Pro polymorphism of thetransforming growth factor-pl with genetic susceptibility toosteoporosis and spinal osteoarthritis. Mechanisms of Ageing andDevelopment ,2000 ,116 : 113-123.
-
5Yamada Y,Ando F,Niino N,et al. Association of polymorphismsof the androgen receptor and klotho genes with bone mineraldensity in Japanese women. J Mol Med,2005 , 83(1) :50-57.
-
6Zarrabeitia MT,Hem6ndez JL, Valero C, et al. Klotho GenePolymorphism and Male Bone Mass. Calcif Tissue Int, 2007 ,80 :10-14.
-
7Yasuhiko Shimoyama,Kazuko Nishio,Nobuyuki Hamajima,et al.Klotho gene polymorphisms G-395A and C1818T are associatedwith lipid and glucose metabolism,bone mineral density andsystolic blood pressure in Japanese healthy subjects. ClinicaChimica Acta,2009 ,406 : 134-138.
-
8Kawano K,Ogata N,Chisano M,et al. Klotho gene polymorphismare associated with bone density of aged postmenopausal women. JBone Miner Res,2002 ,17( 10) :1744-1751.
-
9Mullin BH,Wilson SG, Islam FM, et al. Klotho genepolymorphism are associated with osteocalcin levels but not bonedensity of aged postmenopausal women. Calcif Tissue Int, 2005 ,77(3) :145-151.
-
10Jos6 A. Riancho, Carmen Valero, Jos6 L. Herndndez, et al.Association of the F352V variant of the klotho gene with bonemineral density. Biogerontology ,2007,8 :121-127.
引证文献4
-
1王东麟,赵今.雌激素受体基因多态性与慢性牙周炎相关性的研究进展[J].新疆医科大学学报,2015,38(2):250-252. 被引量:3
-
2马秋华,毛艳华,周晓辉,张清潭.Klotho基因多态性与老年人低骨量的相关性研究[J].中国骨质疏松杂志,2015,21(8):961-967. 被引量:3
-
3付春娟.绝经期骨质疏松患者雌激素替代治疗的效果观察[J].中国医药指南,2016,14(1):84-85. 被引量:6
-
4马秋华,王云文,马慧,齐杰,张清潭.Klotho基因多态性与60岁以上老年原发性骨质疏松症的相关性[J].中国组织工程研究,2019,23(35):5587-5591. 被引量:8
二级引证文献20
-
1江萍,王瑶.观察基础治疗联合牙周维护对慢性牙周炎的治疗作用[J].医学与社会,2015,28(B06):109-109. 被引量:1
-
2徐锋,马厚勋,李宝善,肖碧,黄倩,梁霄.过表达Klotho抑制小鼠RAW264.7细胞向破骨细胞分化[J].细胞与分子免疫学杂志,2017,33(6):731-735.
-
3黄广平,陈民,李腾辉.产后妇女骨质疏松的危险因素分析[J].中国妇幼保健,2017,32(23):5859-5862. 被引量:7
-
4于文亮.激素治疗对更年期综合征患者生存质量的影响观察[J].基层医学论坛,2018,22(23):3224-3225. 被引量:9
-
5尹良胜.慢性牙周炎患者治疗前后血清前列腺特异性抗原水平的变化及意义[J].牙体牙髓牙周病学杂志,2018,28(10):580-584. 被引量:3
-
6陆玉莲,徐畅.阿仑膦酸钠联合雷洛昔芬治疗绝经后骨质疏松效果观察[J].中国乡村医药,2019,26(2):6-7.
-
7张晓奎,裴枫,王新浩.骨质疏松患者Klotho水平变化特点及临床意义研究[J].实验与检验医学,2019,37(3):389-391. 被引量:3
-
8潘晓华,齐一璕,胡芳菲,刘戈,贾芙蓉,高雪.基于网络药理学研究淫羊藿-女贞子药对抗骨质疏松作用机制[J].国际老年医学杂志,2019,40(4):225-228. 被引量:3
-
9马秋华,王云文,马慧,齐杰,张清潭.Klotho基因多态性与60岁以上老年原发性骨质疏松症的相关性[J].中国组织工程研究,2019,23(35):5587-5591. 被引量:8
-
10华诚峰,潘佩婵,利结芳,李玖利,黄金珍,刘晓文.老年骨质疏松症合并2型糖尿病患者中医体质类型与生活习惯的相关性分析[J].齐鲁护理杂志,2020,26(3):40-43. 被引量:12
-
1安胜军,程艳荣.绝经与骨质疏松症发病的分子机制[J].当代医学,2001,7(4):63-66. 被引量:9
-
2张鸿飞,刘汉钧,刘爱武,钱纬,何青雯,陈跃明,贾友兰,李晓燕,蒋海燕.“慢性结肠炎”与炎症性肠病显微及超微病理观察[J].电子显微学报,1993,12(1):63-63.
-
3李军,章玲,梁新剑,罗林杰.巨噬细胞移动抑制因子在自发性高血压大鼠主动脉血管壁上的表达[J].广西医科大学学报,2009,26(3):408-410. 被引量:1
-
4绳丹.骨质疏松症的药物治疗与进展[J].中国药物与临床,2005,5(10):778-780. 被引量:6
-
5刘浩,刘志红,刘栋,陈朝红,黎磊石.狼疮性肾炎患者雌激素受体基因多态性的分布及意义[J].肾脏病与透析肾移植杂志,1999,8(6):517-521. 被引量:1
-
6董砚虎,柳林,李长贵,司元国,吕文山,翟木绪,王海燕,曲宁.糖尿病患者雌激素受体基因多态性与骨密度的相关性研究[J].中华内分泌代谢杂志,2002,18(3):214-218. 被引量:6
-
7谢建萍,龚先琼,谭德明,刘菲,周建亮.雌激素受体基因多态性与乙型肝炎肝硬化的相关性研究[J].中南大学学报(医学版),2006,31(3):379-382. 被引量:15
-
8郭志刚,郑华,吴赛珠,赖文岩,吴迎星,翁心植,裘玉容.雌激素受体基因多态性与冠心病的关系[J].中华老年心脑血管病杂志,2002,4(6):374-377. 被引量:12
-
9王健,徐云霞.“糖友”防“骨松”要补钙[J].养生保健指南(中老年健康),2013(3):57-57. 被引量:1
-
10程爱娟,付乃宽,许静,王佩显.雌激素受体基因多态性与冠心病及血脂关系的研究[J].河北医药,2006,28(7):568-570. 被引量:7